Article Versions Notes

Balkhi S, Bilato G, De Lerma Barbaro A, Orecchia P, Poggi A, Mortara L. Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies. Vaccines. 2025; 13(1):69. https://doi.org/10.3390/vaccines13010069

Balkhi, Sahar, Giorgia Bilato, Andrea De Lerma Barbaro, Paola Orecchia, Alessandro Poggi, and Lorenzo Mortara. 2025. "Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies" Vaccines 13, no. 1: 69. https://doi.org/10.3390/vaccines13010069

Balkhi, S., Bilato, G., De Lerma Barbaro, A., Orecchia, P., Poggi, A., & Mortara, L. (2025). Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies. Vaccines, 13(1), 69. https://doi.org/10.3390/vaccines13010069